| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |